Case report of a patient with benign subdural extramedullary tumor treated with combined administration of gabapentin and duloxetine

  • KAGEYAMA Megumi
    Department of Anesthesiology, Dokkyo Medical University School of Medicine
  • HAMAGUCHI Shinsuke
    Department of Anesthesiology, Dokkyo Medical University School of Medicine
  • MATSUZAWA Rie
    Department of Anesthesiology, Dokkyo Medical University School of Medicine
  • HIGASHI Naoko
    Department of Anesthesiology, Dokkyo Medical University School of Medicine
  • IKEDA Tomohito
    Department of Anesthesiology, Dokkyo Medical University School of Medicine
  • YAMAGUCHI Shigeki
    Department of Anesthesiology, Dokkyo Medical University School of Medicine

Bibliographic Information

Other Title
  • ガバペンチンとデュロキセチンの併用が有効であった硬膜内髄外腫瘍症例の治療経験
  • ガバペンチン ト デュロキセチン ノ ヘイヨウ ガ ユウコウ デ アッタ コウマク ナイズイガイ シュヨウ ショウレイ ノ チリョウ ケイケン

Search this article

Abstract

A 42-year-old male had continuous pain in his back, hip, and bilateral lower extremities. A lumbar MRI showed a small subdural extramedullary tumor behind the L3 vertebral body. However, removal of the tumor was not adopted because the doctors determined that it was not the cause of his neurological findings. Before his visit to our outpatient service, he had been treated with various antidepressants, anticonvulsants, and analgesics, including opioid alone or in combination. However, previous treatments were ineffective. We diagnosed his pain as neuropathic and prescribed a combined 400 mg of gabapentin and 60 mg of duloxetine a day after confirmation of his past medication history. Four weeks after daily administration of these drugs, his pain had decreased to 5/10, from 10/10, determined by use of a pain scale. We concluded that the combined administration of various adjuvant analgesics can be useful for neuropathic pain relief when analgesic administration with no combined administration was ineffective treatment for intractable pain.

Journal

References(9)*help

See more

Details 詳細情報について

Report a problem

Back to top